Skip to content

Medical emergency? What to do

Study finds drug stents often not cost-effective

3-RXPublished September 8, 20052 min read

Key points

  • Popular new drug-coated devices to keep arteries open are not cost-effective for many heart patients and their use could be restricted to high-risk groups, researchers said on Tuesday.
  • They are increasingly being used instead of older bare metal stents.
  • Overall, the average cost of six months of treatment using a drug eluting stent was 10,544 euros ($13,230), or 900 euros more than for bare stents.
  • Those patients most likely to benefit from drug eluting stents included the elderly and people needing multiple or particularly complicated procedures.

Popular new drug-coated devices to keep arteries open are not cost-effective for many heart patients and their use could be restricted to high-risk groups, researchers said on Tuesday.

The worldwide market for drug-eluting stents -- tiny wire-mesh tubes that hold open cleared arteries while dispersing a medicine to prevent re-clogging -- is $5.5 billion and growing fast.

They are increasingly being used instead of older bare metal stents.

But an 826-patient Swiss study found that although the newer devices worked better than the older ones, they were not cost-effective because they were more expensive and did not substantially reduce the costs of follow-up patient care.

Overall, the average cost of six months of treatment using a drug eluting stent was 10,544 euros ($13,230), or 900 euros more than for bare stents. Their high initial price was not compensated by lower follow-up costs.

"The use of drug eluting stents could be restricted to certain high-risk patient groups, at least until the prices fall," said Professor Matthias Pfisterer of the University of Basel, Switzerland.

Those patients most likely to benefit from drug eluting stents included the elderly and people needing multiple or particularly complicated procedures.

Patients requiring a short stent generally fared well with bare metal, he said.

USE RISING FAST

In the United States, drug eluting devices account for more than 80 percent of the stent market and their use in Europe is also growing fast, Pfisterer said.

Clinicians and patients have been attracted to the new products because the medication they are coated with helps stop blood vessels from closing up again.

Pfisterer and his colleagues presented their findings to the European Society of Cardiology congress and the research was also published online by the Lancet medical journal.

The study compared three sets of patients, who were randomly given either Johnson & Johnson's drug-coated Cypher stent, Boston Scientific Corp's drug-coated Taxus stent or a bare metal device.

Pfisterer said the Cypher product appeared slightly more effective in preventing cardiovascular complications than the Taxus one, but the difference was not statistically significant.

Johnson & Johnson and Boston Scientific currently dominate the drug-eluting stent market but rivals are now arriving on the scene and Pfisterer said this could help bring down prices in the longer term.

New competitors include Medtronic Inc.'s Endeavor device, launched in Europe last month, and Sorin SpA's Janus product, which reported positive six-month clinical trial results at this week's cardiology conference.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underPublic Health
Public Health

Parasitic DNA proliferates in aging tissues

The genomes of organisms from humans to corn are replete with "parasitic" strands of DNA that, when not suppressed, copy themselves and spread throughout the genome, potentially affecting health. Earlier this year…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.